X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Concentrating on high value - Views on News from Equitymaster
 
 
  • PRINT
  • E-MAIL
  • FEEDBACK
  • A  A  A
  • Jan 5, 1999

    Concentrating on high value

    Highlights

    • Procter and Gamble India Limited P&G is a 65% subsidiary of the US$ 35 bn global giant Procter & Gamble, USA. P&G is a market leader in the anti-cold healthcare (Vicks), feminine care (Whisper sanitary napkins) and men's toiletries (Old Spice) businesses. It also manufactures Clearasil cream.
    • The parent has 3 companies in India - P&G India, P&G Home Products (a 100% subsidiary) and P&G Distribution.
    • P&G's distribution is largely urban with a combined reach of 0.5 m outlets.
    • P&G acts as a contract manufacturer of detergents (Ariel) and shampoos (Head & Shoulders, Pantene) for P&G Home Products, which markets the aforesaid products

    Healthcare (Anti-cold) segment (40% of FY98 revenues)

    • This segment consists of menthol-based products in numerous forms like rub and cream, tablets and cough drops, lozenges and inhalers. 
    • P&G's brand Vicks operates in all the aforesaid forms and is the No. 1 brand with 35% market share in the Rs 4 bn anti-cold healthcare segment. Overall, this segment is growing at 17-18%  per annum. Vicks main competitors in this segment are Amrutanjan, Zandu and Warner-Lambert (Halls).
    Feminine Care (13% of FY98 revenues)
    • P&G's Whisper dominates the Rs 1.8 bn sanitary napkins market with a 50% market share (in value terms). Whisper operates in the premium range, meaning high margins and low volumes. 
    • This segment is growing annually at 25-30%. The segment has low awareness and penetration levels (10-12% in urban areas). P&G competes with Johnson & Johnson (Stayfree, Carefree) and Kimberley Clarke-HLL (Kotex, Secure).

    Men's Toiletries (12% of FY98 revenues)

    • P&G's products consist mainly of Old Spice range of shaving cream, after-shave lotions, hair cream, deodorants and talcum powder in this segment. In shaving cream,Colgate Palmolive is  the market leader with 28% market share, followed by Old Spice at 16%.
    • Old Spice after-shave is the market leader with more than 50% share. P&G competes with HLL's Denim and Park Avenue of JK Helene Curtis in this segment. The Rs 1.5 bn men's  toiletries market is growing 15-20% per annum.
    Contract manufacturing (35% of FY98 revenues)
    • P&Gmanufactures the Ariel range of detergents and Head & Shoulders and Pantene range of shampoos for P&G Home Products. It enjoys assured net margins (cost plus 5%) on these products.

    Skin Care

    • P&G manufactures Clearasil an anti-acne cream, which has been growing at 5-6%, compared to the industry average of 15%. Lakme, Ponds, Charmis and Fair & Lovely are the other major brands in this segment.
    Concerns
    • Parent focus on P&G Home Products. All future product launches in fabric-wash, hair-care, cosmetics and oral-care segment will take place through this 100% subsidiary. 
    • Though it will shield P&G from high costs of product launches and brand building, at the same time it will deprive it of leveraging P&G,USA's global brands and high growth areas.
    Future
    • P&G to focus on its three businesses - healthcare, feminine care and skin care through brand extensions. It will also provide manufacturing base for group companies.
    • The company has proposed changing its name to Procter and Gamble Hygiene and Healthcare to better reflect the nature of its business.

     

     

    Equitymaster requests your view! Post a comment on "Concentrating on high value". Click here!

      
     

    More Views on News

    P&G: Strong Core Growth (Quarterly Results Update - Detailed)

    Dec 9, 2016

    Procter & Gamble Hygiene and Health Care has announced the first quarter results of the financial year ended June 2017 (1QFY17). The company's sales rose by 12.5%YoY while net profit rose by 50.1% YoY during the quarter.

    P&G: Strong Core Performance (Quarterly Results Update - Detailed)

    Oct 5, 2016

    Procter & Gamble Hygiene and Health Care reported a 0.1% YoY growth in sales and a 2.2% YoY increase in net profits during the quarter ended June 2016.

    Marico: Earnings Hit by Lower Volumes and Firming Input Prices (Quarterly Results Update - Detailed)

    Aug 9, 2017

    While GST implementation brought down volumes and profitability in the short run, Marico remains optimistic in the long run.

    P&G: A Stable Quarter (Quarterly Results Update - Detailed)

    May 6, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 12% YoY during the quarter.

    P&G: Margins Go Through the Roof (Quarterly Results Update - Detailed)

    Feb 9, 2016

    Procter & Gamble Hygiene and Health Care reported an 11% YoY increase in revenues, while profits rose by 62% YoY during the quarter.

    More Views on News

    Most Popular

    This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

    Aug 17, 2017

    A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

    The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

    Aug 10, 2017

    Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    Bitcoin Continues Stellar Rise(Chart Of The Day)

    Aug 10, 2017

    Bitcoin hits an all-time high, is there more upside left?

    5 Steps To Become Financially Independent(Outside View)

    Aug 16, 2017

    Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

    More
    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407
     

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms

    P&G HYGIENE SHARE PRICE


    Aug 23, 2017 10:03 AM

    TRACK P&G HYGIENE

    • Track your investment in P&G HYGIENE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks

    P&G HYGIENE 8-QTR ANALYSIS

    Detailed Quarterly Results With Charts

    COMPARE P&G HYGIENE WITH

    MARKET STATS